share_log

Pfizer | DEFA14A: Others

Pfizer | DEFA14A: Others

辉瑞 | DEFA14A:其他
美股sec公告 ·  04/11 11:00
Moomoo AI 已提取核心信息
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement schedule 14A, in accordance with Section 14(a) of the Securities Exchange Act of 1934. The materials were submitted by Pfizer as the registrant, indicating that no third parties were involved in the filing. The company confirmed that no filing fee was required for this submission. The purpose of the filing and the contents of the additional materials have not been specified in the announcement.
Pfizer Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement schedule 14A, in accordance with Section 14(a) of the Securities Exchange Act of 1934. The materials were submitted by Pfizer as the registrant, indicating that no third parties were involved in the filing. The company confirmed that no filing fee was required for this submission. The purpose of the filing and the contents of the additional materials have not been specified in the announcement.
根据1934年《证券交易法》第14(a)条,辉瑞公司已向美国证券交易委员会(SEC)提交了明确的补充材料,作为其委托声明附表14A的一部分。这些材料由辉瑞作为注册人提交,表明申请中没有第三方参与。该公司证实,此次提交不需要任何申请费。公告中没有具体说明申报目的和补充材料的内容。
根据1934年《证券交易法》第14(a)条,辉瑞公司已向美国证券交易委员会(SEC)提交了明确的补充材料,作为其委托声明附表14A的一部分。这些材料由辉瑞作为注册人提交,表明申请中没有第三方参与。该公司证实,此次提交不需要任何申请费。公告中没有具体说明申报目的和补充材料的内容。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息